Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AxoGen Nerve Cap

K-Number: K163446 · 2017-08-08

Decision Date2017-08-08
Product CodeJXI
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

AxoGen Nerve Cap is a medical device manufactured by Axogen Corporation. It received FDA 510(k) clearance on 2017-08-08 under approval number K163446. The device is classified under product code JXI. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AxoGen Nerve Cap?

AxoGen Nerve Cap is a medical device that received FDA 510(k) clearance on 2017-08-08. It is manufactured by Axogen Corporation. The 510(k) number is K163446.

When was AxoGen Nerve Cap approved by the FDA?

AxoGen Nerve Cap received FDA 510(k) clearance on 2017-08-08, under approval number K163446.

What company makes AxoGen Nerve Cap?

AxoGen Nerve Cap is manufactured by Axogen Corporation.

What is the FDA product code for AxoGen Nerve Cap?

The FDA product code for AxoGen Nerve Cap is JXI.

Other Devices by Axogen Corporation

Related Devices (Code: JXI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.